ARGX stock profile
Argen X SE Company Profile
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Company information
- Company Name Argen X SE
- Industry Biological Product (except Diagnostic) Manufacturing
- CEO Tim Van Hauwermeiren
- Security Name Argen X SE - ADR
- Sector Manufacturing
- Employees 336
- Exchange NASDAQ
- Country Netherlands
- State Noord Brabant
- City Breda
- Address Willemstraat 5
- Phone 31763030488
- Website https://www.argenx.com/
- Zip 4811 AH
Peers
- OVAT-CA
- OVID
- OVIT
- OYST
Top Executives
- Entity Name
- Position
- Report Date
Related News

Can NASDAQ:BIDU Surge Above $200? How Will AI and Robotaxi Businesses Impact Baidu’s Future Price?
TradingNEWS Archive
10.05.25

Is NASDAQ: INTC Ready for a Strong Recovery in 2025?
TradingNEWS Archive
10.05.25

Shell’s Bold Move: Can a Potential BP Acquisition Propel NYSE:SHEL to New Heights Amid $60 Brent Prices?
TradingNEWS Archive
09.05.25

Adobe Inc. (NASDAQ:ADBE) Shows Resilience in Volatile Market – Undervalued or Overlooked Opportunity?
TradingNEWS Archive
09.05.25